A pH-responsive metal–lignin nanozyme microneedle system for stage-adapted therapy of infected skin wounds
Journal of Controlled Release · 2026
DOI: 10.1016/j.jconrel.2026.115207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2026. Verfasst von Jiaying Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy…. Hauptthemen laut MEDLINE: Lignin, Wound Infection, Anti-Bacterial Agents. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Infected wounds feature a dynamic microenvironment characterized by persistent bacterial infection and excessive reactive oxygen species (ROS), yet existing therapies often lack the ability to dynamically adapt to the evolving wound microenvironment. We developed a microenvironment-responsive microneedle delivery system (RuCe@D-P MNs) integrating a bimetallic lignin nanozyme for spatiotemporally adaptive wound therapy. The optimal RuCe@D-P nanozyme was synthesized by screening lignin-metal assemblies based on assembly yield, particle size, and enzyme-like activities (peroxidase/superoxide dismutase/catalase). This nanozyme was incorporated into a sodium alginate/polyvinylpyrrolidone microneedle array, where spontaneous metal-carboxylate coordination cross-linking significantly enhanced the mechanical strength and puncture integrity of the microneedles. Crucially, the RuCe@D-P MN system exhibited coordinated pH-responsive release and catalytic behaviors: under acidic infection-associated conditions, accelerated release of RuCe@D-P nanozymes, together with their POD-like activity promoted bacterial suppression; as the wound microenvironment evolved toward less acidic, near-neutral, or weakly alkaline conditions during healing, RuCe@D-P release became more sustained, and the dominant enzyme-like activity shifted toward SOD/CAT-like activity, thereby scavenging ROS and modulating the immune microenvironment to support tissue regeneration. This scalable, self-cross-linking microneedle platform provides an adaptive spatiotemporal strategy for managing complex infected wounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 101408, China.
- State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
- Medical Center for Endocrine and Metabolic Diseases, Rheumatic and Immunologic Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China; Beijing Key Laboratory of Artificial Intelligence and Ce…
- State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China. Electronic address: fankelong@ibp.ac.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xie, J., Cheng, A., Gao, S., Sun, S., Xu, R., Yan, X., Zhao, D., & Fan, K. (2026). A pH-responsive metal–lignin nanozyme microneedle system for stage-adapted therapy of infected skin wounds. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115207
Vancouver
Xie J, Cheng A, Gao S, Sun S, Xu R, Yan X, et al. A pH-responsive metal–lignin nanozyme microneedle system for stage-adapted therapy of infected skin wounds. Journal of Controlled Release. 2026. doi:10.1016/j.jconrel.2026.115207
BibTeX
@article{Xie2026,
author = {Xie, Jiaying and Cheng, Aguo and Gao, Sai and Sun, Shuhao and Xu, Ran and Yan, Xiyun and Zhao, Dong and Fan, Kelong},
title = {A pH-responsive metal–lignin nanozyme microneedle system for stage-adapted therapy of infected skin wounds},
journal = {Journal of Controlled Release},
year = {2026},
doi = {10.1016/j.jconrel.2026.115207}
}
EUVIMED